Current market catalysts

8-K filing — NEKTAR THERAPEUTICS (NKTR)

Filed: 2026-09-08 AccNo: 0001213900-26-098042 Size: 187 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Snap Inc (SNAP)

Filed: 2026-09-08 AccNo: 0001193125-26-385199 Size: 132 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Chime Inks Deal To Acquire Stride Bank For $950M

ServiceTitan Q2 Adj. EPS $0.40 Beats $0.35 Estimate, Sales $292.756M Beat $285.957M Estimate

Braze Q2 Adj. EPS $0.19 Beats $0.16 Estimate, Sales $227.230M Beat $219.918M Estimate

InnovAge Holding Q4 EPS $0.06 Misses $0.07 Estimate, Sales $261.951M Beat $238.267M Estimate

Broadcom CEO Says Capital Allocation Likely To Focus On Increased Dividends, Stock Buybacks

InnovAge Holding Sees FY2027 Sales $1.050B-$1.085B vs $1.038B Est

ServiceTitan Raises FY2027 Sales Guidance from $1.130B-$1.140B to $1.139B-$1.144B vs $1.138B Est

Braze Sees Q3 Adj EPS $0.13-$0.14 vs $0.16 Est; Sees Sales $229.000M-$230.000M vs $227.861M Est

Suniva Announces Completion Of $835M Debt And Equity Raise To Fund 4.5 GW South Carolina Solar Cell Plant; Expects Completion Late 2027

ServiceTitan Sees Q3 Sales $285.000M-$287.000M vs $287.874M Est

LiqTech International Announces David Noerby Foss Kowalczyk To Resign As CFO And COO Effective November 30, 2026

Braze Raises FY2027 Adj EPS Guidance from $0.61-$0.65 to $0.64-$0.65 vs $0.63 Est; Raises FY2027 Sales Guidance from $884.000M-$889.000M to $910.000M-$913.000M vs $898.085M Est

Protagonist Therapeutics Announces $300M Buyback Plan

Carlsmed Announces Promotion Of Jeff Bertolini To COO, Effective Immediately

Mission Produce Q3 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $450.000M Beat $367.475M Estimate

8-K filing — Everus Construction Group, Inc. (ECG)

Filed: 2026-09-08 AccNo: 0002015845-26-000056 Size: 169 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K filing — Braze, Inc. (BRZE)

Filed: 2026-09-08 AccNo: 0001676238-26-000039 Size: 705 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Braveheart Bio, Inc. (BRVE)

Filed: 2026-09-08 AccNo: 0001628280-26-060904 Size: 367 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Wheeler Real Estate Investment Trust, Inc. (WHLRL)

Filed: 2026-09-08 AccNo: 0001527541-26-000331 Size: 196 KB Item 3.02: Unregistered Sales of Equity Securities

8-K filing — ServiceTitan, Inc. (TTAN)

Filed: 2026-09-08 AccNo: 0001638826-26-000093 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — BJ's Wholesale Club Holdings, Inc. (BJ)

Filed: 2026-09-08 AccNo: 0001104659-26-105906 Size: 186 KB Item 8.01: Other Events

8-K filing — CARLSMED, INC. (CARL)

Filed: 2026-09-08 AccNo: 0001794546-26-000018 Size: 181 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — SANGAMO THERAPEUTICS, INC (SGMOQ)

Filed: 2026-09-08 AccNo: 0001104659-26-105905 Size: 4 MB Item 1.03: Bankruptcy or Receivership Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — FIRST COMMUNITY CORP /SC/ (FCCO)

Filed: 2026-09-08 AccNo: 0001552781-26-000475 Size: 14 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — XCF Global, Inc. (SAFX)

Filed: 2026-09-08 AccNo: 0001493152-26-041766 Size: 318 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

8-K filing — Medalist Diversified, Inc. (MDRR)

Filed: 2026-09-08 AccNo: 0001104659-26-105902 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

8-K filing — Cytosorbents Corp (CTSO)

Filed: 2026-09-08 AccNo: 0001104659-26-105901 Size: 205 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

8-K filing — Intellia Therapeutics, Inc. (NTLA)

Filed: 2026-09-08 AccNo: 0001193125-26-385194 Size: 257 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits